Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 10, 2021

SELL
$232.72 - $256.47 $1.51 Million - $1.66 Million
-6,482 Closed
0 $0
Q2 2021

Aug 09, 2021

SELL
$232.65 - $254.58 $638,856 - $699,076
-2,746 Reduced 29.76%
6,482 $1.58 Million
Q1 2021

May 13, 2021

SELL
$232.09 - $256.88 $446,773 - $494,494
-1,925 Reduced 17.26%
9,228 $2.24 Million
Q4 2020

Feb 08, 2021

SELL
$221.92 - $245.94 $2.41 Million - $2.67 Million
-10,870 Reduced 49.36%
11,153 $2.79 Million
Q3 2020

Oct 30, 2020

SELL
$215.77 - $276.76 $771,809 - $989,970
-3,577 Reduced 13.97%
22,023 $5.13 Million
Q2 2020

Aug 05, 2020

SELL
$219.9 - $263.41 $219,900 - $263,410
-1,000 Reduced 3.76%
25,600 $6.12 Million
Q1 2020

May 05, 2020

SELL
$195.69 - $279.01 $117,414 - $167,406
-600 Reduced 2.21%
26,600 $6.1 Million
Q4 2019

Feb 07, 2020

BUY
$236.45 - $266.82 $47,290 - $53,364
200 Added 0.74%
27,200 $7.39 Million
Q2 2019

Jul 29, 2019

SELL
$217.4 - $246.08 $7.61 Million - $8.61 Million
-35,000 Reduced 56.45%
27,000 $6.8 Million
Q4 2018

Feb 06, 2019

SELL
$204.73 - $257.93 $2.46 Million - $3.1 Million
-12,000 Reduced 16.22%
62,000 $14 Million
Q2 2018

Jul 30, 2018

BUY
$208.1 - $233.85 $6.56 Million - $7.37 Million
31,500 Added 74.12%
74,000 $17.7 Million
Q1 2018

Apr 26, 2018

BUY
$205.46 - $240.27 $3.39 Million - $3.96 Million
16,500 Added 63.46%
42,500 $9.21 Million
Q4 2017

Feb 06, 2018

SELL
$189.0 - $222.64 $189,000 - $222,640
-1,000 Reduced 3.7%
26,000 $5.57 Million
Q3 2017

Oct 30, 2017

BUY
$186.89 - $198.9 $5.05 Million - $5.37 Million
27,000
27,000 $5.29 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $65.2B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Bp PLC Portfolio

Follow Bp PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bp PLC, based on Form 13F filings with the SEC.

News

Stay updated on Bp PLC with notifications on news.